Analystreport

Mersana Therapeutics (NASDAQ:MRSN) had its "neutral" rating reaffirmed by analysts at Guggenheim.

Mersana Therapeutics, Inc.  (MRSN) 
Last mersana therapeutics, inc. earnings: 2/28 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: mersana.com/about-mersana